Last November, more than 15 000 clinicians alighted on Chicago for the American Heart Association (AHA) Scientific Sessions, the group’s annual flagship conference. The meeting featured the release of the federal government’s physical activity guidelines and results from several high-profile clinical trials, like VITAL and REDUCE-IT and DECLARE-TIMI 58. The announcements also included new cholesterol clinical practice guidelines from the AHA, the American College of Cardiology (ACC), and several other organizations, the first update since 2013.
Abbasi J. New Cholesterol Guidelines Personalize Risk and Add Treatments. JAMA. Published online February 06, 2019321(8):731–732. doi:10.1001/jama.2018.21019
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: